Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pasello

Showing results (51-60 of 167) with videos related to

Pageof 17
Sort By:
Diagnostics (Basel, Switzerland)|June 2, 2021
Diagnostic Challenges in Epithelioid Pleural Mesothelioma: Case Series with Support from Electron MicroscopyFrancesco Fortarezza, Mila Della Barbera, Federica Pezzuto, et al.
International Journal of Molecular Sciences|June 28, 2023
Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?Calogera Claudia Spagnolo, Giuliana Ciappina, Elisa Giovannetti, et al.
Pathology, Research and Practice|May 21, 2026
Mesothelioma in situ-spectrum pleural lesions: Diagnostic challenges and longitudinal follow-up in a case seriesFederica Pezzuto, Chiara Giraudo, Davide Biondini, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2025
Circulating microRNAs as biomarkers for risk assessment and prognostic stratification of pleural mesotheliomaEvgeniya Sharova, Paola Del Bianco, Loredana Urso, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2010
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysisRoy Sidi, Giulia Pasello, Isabelle Opitz, et al.
The American Journal of Case Reports|November 4, 2015
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the LiteratureValentina Polo, Giulia Zago, Stefano Frega, et al.
Oncotarget|June 1, 2017
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonistsLoredana Urso, Ilaria Cavallari, Micol Silic-Benussi, et al.
Frontiers in Oncology|July 24, 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysisGiulia Pasello, Alberto Pavan, Mattia De Nuzzo, et al.
Anticancer Research|December 29, 2010
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinomaLaura Bonanno, Marco Schiavon, Giorgia Nardo, et al.
International Journal of Molecular Sciences|April 23, 2022
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung CancerFiorella Calabrese, Federica Pezzuto, Francesca Lunardi, et al.
Pageof 17

Showing results (51-60 of 167) with videos related to

Sort By:
Pageof 17
Diagnostics (Basel, Switzerland)|June 2, 2021
Diagnostic Challenges in Epithelioid Pleural Mesothelioma: Case Series with Support from Electron MicroscopyFrancesco Fortarezza, Mila Della Barbera, Federica Pezzuto, et al.
International Journal of Molecular Sciences|June 28, 2023
Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?Calogera Claudia Spagnolo, Giuliana Ciappina, Elisa Giovannetti, et al.
Pathology, Research and Practice|May 21, 2026
Mesothelioma in situ-spectrum pleural lesions: Diagnostic challenges and longitudinal follow-up in a case seriesFederica Pezzuto, Chiara Giraudo, Davide Biondini, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2025
Circulating microRNAs as biomarkers for risk assessment and prognostic stratification of pleural mesotheliomaEvgeniya Sharova, Paola Del Bianco, Loredana Urso, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2010
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysisRoy Sidi, Giulia Pasello, Isabelle Opitz, et al.
The American Journal of Case Reports|November 4, 2015
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the LiteratureValentina Polo, Giulia Zago, Stefano Frega, et al.
Oncotarget|June 1, 2017
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonistsLoredana Urso, Ilaria Cavallari, Micol Silic-Benussi, et al.
Frontiers in Oncology|July 24, 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysisGiulia Pasello, Alberto Pavan, Mattia De Nuzzo, et al.
Anticancer Research|December 29, 2010
Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinomaLaura Bonanno, Marco Schiavon, Giorgia Nardo, et al.
International Journal of Molecular Sciences|April 23, 2022
Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung CancerFiorella Calabrese, Federica Pezzuto, Francesca Lunardi, et al.
Pageof 17